COMPOUNDS FOR AND A METHOD OF INHIBITING MATRIX METALLOPROTEINASES

The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds.wherein Q is an un-natural amino acid. More particurlarly, the present invention relates to a method of treating diseases in whic...

Full description

Saved in:
Bibliographic Details
Main Author DRAGO ROBERT SLISKOVIC
Format Patent
LanguageEnglish
Published 31.12.1998
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds.wherein Q is an un-natural amino acid. More particurlarly, the present invention relates to a method of treating diseases in which matrix metalloproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, arthiritis, or other autoimmune or inflammatory diseases dependent upon tissue invasion by leukocytes.
AbstractList The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds.wherein Q is an un-natural amino acid. More particurlarly, the present invention relates to a method of treating diseases in which matrix metalloproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, arthiritis, or other autoimmune or inflammatory diseases dependent upon tissue invasion by leukocytes.
Author DRAGO ROBERT SLISKOVIC
Author_xml – fullname: DRAGO ROBERT SLISKOVIC
BookMark eNrjYmDJy89L5WRwcvb3DfAP9XMJVnDzD1Jw9HNRcFTwdQ3x8HdR8HdT8PTz8HTyDPH0c1fwdQwJ8owAyTn6-PgHBPmHuHr6OQa7BvMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkniPoABLcwMTcxNHI2MilAAAyCAs9w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID HRP970474A2
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP970474A23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:56:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP970474A23
Notes Application Number: HR1997P000474
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981231&DB=EPODOC&CC=HR&NR=P970474A2
ParticipantIDs epo_espacenet_HRP970474A2
PublicationCentury 1900
PublicationDate 19981231
PublicationDateYYYYMMDD 1998-12-31
PublicationDate_xml – month: 12
  year: 1998
  text: 19981231
  day: 31
PublicationDecade 1990
PublicationYear 1998
RelatedCompanies DRAGO ROBERT SLISKOVIC
RelatedCompanies_xml – name: DRAGO ROBERT SLISKOVIC
Score 2.4971404
Snippet The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS FOR AND A METHOD OF INHIBITING MATRIX METALLOPROTEINASES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981231&DB=EPODOC&locale=&CC=HR&NR=P970474A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5jivqmU3H-Ig_St2K3tY19KNI2ra2sSamd7G20aQZ76Yar-O97C9v0Rd-OHByXwHeXS3JfEHqQppSQ9RzdqQgUKE-k1kurHOhzR45s4dTCULSLKbPjifk6taYdtNj1wiie0C9FjgiIEoD3VsXr1c8hFlVvK9eP1QKGls9R4VKt3rWLQSAeaNR3w4xTHmhB4Ma5xnI3c4hhEtODaH0Au2iyAUP47m-aUla_M0p0ig4zMNa0Z6gjmx46DnYfr_XQUbq97wZxC731OfIDnmZ8wugbhsINe4xiD6dhEXOKeYQTFid-UiTsBadekSfTjc4bj3mW8yJMmAdx8wLhKCyCWAdnZvuJz-J87_boEnWbZSOvEJ4PhSAAxqGwDLMWg7IuCch2KQy7Arj1Uf9PM9f_6G7QiWq4UyyGt6jbfnzKO8i4bXWv1uobcOyAOg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCA2Xjmg3iq6rWvpoUJ90kKbVKVDu01t2km7dBMr4u_jRdvgAjcrliwn0mfHSfwF4L5SqwqzniEbhY4FyqNeyvk4H8hzoxpp3Ci5ImgXY6oFE_VlOp62YLHrhRE8oV-CHBERxRHvjYjXq59DLFe8rVw_FAscWj75melK5a5dDAPxQHJt00uYyxzJccwglWhqJoauqLpqYbQ-wB22vgGD925vmlJWvzOKfwKHCRqrm1NoVXUXOs7u47UuHMXb-24Ut9Bbn4HtsDhhE-q-ESzciEVdYpHYywLmEuaTkAahHWYhfSaxlaXhdKOzooglKcu8kFoYN8-B-F7mBDI6M9tPfBake7dHF9Cul3V1CWQ-5FxHMA75WFFLPsjLXEdZy7miFQi3HvT-NNP_R3cHnSCLo1kU0tcrOBbNd4LR8BrazcdndYPZtyluxbp9A59Agy0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+FOR+AND+A+METHOD+OF+INHIBITING+MATRIX+METALLOPROTEINASES&rft.inventor=DRAGO+ROBERT+SLISKOVIC&rft.date=1998-12-31&rft.externalDBID=A2&rft.externalDocID=HRP970474A2